Enovis (NYSE: ENOV) today announced it would acquire Novastep and its foot and ankle minimally invasive surgical (MIS) platform for an undisclosed amount. The transaction is subject to customary conditions and regulatory approvals. It is expected to close in the second quarter of 2023. Novastep generates about $20 million in annual revenue. Its MIS platform, […]
Enovis
Enovis stock slides on Q4 revenue miss
Enovis (NYSE:ENOV) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast. Shares of ENOV dropped 5.3% to $58.33 apiece in mid-afternoon trading today. The Wilmington, Delaware-based orthopedic device maker posted losses of $38.6 million. That amounts to losses of 71¢ per share on sales of $408.7 million for […]
Enovis expands foot and ankle portfolio with new staples
Enovis (NYSE: ENOV) today announced the launch of its procedure-specific DynaClip Delta and DynaClip Quattro bone staples. The staples are the latest additions to Wilmington, Delaware–based Enovis’ growing foot and ankle portfolio. The portfolio includes the DynaClip family of bone fixation systems. DynaClip Delta and DynaClip Quattro staples come pre-loaded on disposable inserters. The inserters […]
Enovis wins FDA nod for patient-specific Star Ankle instrumentation
Enovis (NYSE:ENOV) announced today that the FDA approved the STAR patient-specific instrumentation for use with the STAR total ankle replacement system. Wilmington, Delaware–based Enovis designed the STAR PSI system to provide a personalized preoperative plan for each patient. Surgeons receive and review a 3D visualization of the patient’s ankle joint. This includes information about existing […]
Enovis introduces DynaNail Helix for hindfoot fusions
Enovis Corp. (NYSE: ENOV) has launched the DynaNail Helix —the latest addition to its DynaNail family and suite of foot and ankle products. As with other DynaNail systems, DynaNail Helix uses proprietary, nitinol-based materials technology. The NiTiNOL tech provides sustained dynamic compression properties for subtalar fusion. At the same time, Enovis sought to give it […]
Enovis stock dips as it beats The Street in Q3, tightens guidance range
Enovis (NYSE:ENOV) shares took a hit today on third-quarter results that came in ahead of the consensus forecast. Shares of ENOV dipped 3.4% at $47.89 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose by 1%. The Wilmington, Delaware-based company posted losses […]
Enovis makes pair of business unit leadership changes
Enovis (NYSE:ENOV) announced that it appointed Terry Ross and Guy Guglielmino to new leadership roles within the company. Wilmington, Delaware–based Enovis — the parent company of DJO — says the appointments help to drive its growth. The company named Ross, who currently serves as president of Enovis recovery sciences, as the president of Enovis bracing […]
Enovis opens new manufacturing plant in Austin
Enovis (NYSE:ENOV) announced that it opened a state-of-the-art manufacturing facility in Austin, Texas last week. The company held a ribbon-cutting ceremony for the facility’s opening on Sept. 27. President of Enovis Surgical, Louis Vogt, and VP of Operations, Shayne Myhand, attended the event. The 40,000-square-foot ISO 9001-certified center complements Enovis’ existing 75,000-square-foot manufacturing facility. Wilmington, […]
The 10 largest orthopedic device companies in the world
Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s 10 largest orthopedic […]
Enovis more than doubles earnings in Q2, scales back EPS guidance
Enovis (NYSE: ENOV) today reported Q2 results that beat The Street on earnings but missed on revenue, with the ortho device company joining the host of medtech companies scaling back earnings projections for the year amid macroeconomic headwinds. Wilmington, Delaware–based Enovis — the parent company of DJO — earned $121 million, or $2.21 per diluted […]
Enovis launches augmented reality surgical guidance system
Enovis (NYSE:ENOV) announced today that it began the commercial launch of the Arvis (augmented reality visualization and information system). Wilmington, Delaware-based Enovis — the parent company of DJO Global — earlier this month completed the acquisition of Insight Medical and its Arvis FDA-cleared augmented reality platform for hip and knee replacement surgery. According to a news […]